Cell therapy for Parkinson's disease: have the glory days gone?

Affiliations

Comment

Alberto Albanese. Lancet Neurol. 2011 Jun.

. 2011 Jun;10(6):492-3.

doi: 10.1016/S1474-4422(11)70101-6. Epub 2011 May 10.

¹ Istituto Neurologico Carlo Besta, Università Cattolica del Sacro Cuore, Milan, Italy. alberto.albanese@unicatt.it

No abstract available

Comment on

Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial.
Gross RE, Watts RL, Hauser RA, Bakay RA, Reichmann H, von Kummer R, Ondo WG, Reissig E, Eisner W, Steiner-Schulze H, Siedentop H, Fichte K, Hong W, Cornfeldt M, Beebe K, Sandbrink R; Spheramine Investigational Group. Gross RE, et al. Lancet Neurol. 2011 Jun;10(6):509-19. doi: 10.1016/S1474-4422(11)70097-7. Epub 2011 May 10. Lancet Neurol. 2011. PMID: 21565557 Clinical Trial.